Sign in to view content

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2017

Related

Partnerships With Primary Care
Jose Agustin Martinez, MD
Updates from the Field
2025
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Population Pharmacokinetics and Safety of OPT-302 an Anti-VEGF-C--D Trap in Patients With Retinal Vascular Diseases
Dante Joseph Pieramici, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more